These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16278400)

  • 1. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target.
    Ohuchida K; Mizumoto K; Ishikawa N; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2005 Nov; 11(21):7785-93. PubMed ID: 16278400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples.
    Ohuchida K; Mizumoto K; Yu J; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):649-54. PubMed ID: 17416753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients.
    Vimalachandran D; Greenhalf W; Thompson C; Lüttges J; Prime W; Campbell F; Dodson A; Watson R; Crnogorac-Jurcevic T; Lemoine N; Neoptolemos J; Costello E
    Cancer Res; 2005 Apr; 65(8):3218-25. PubMed ID: 15833853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated expression of S100A6 in human gastric cancer.
    Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH
    J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis.
    Ohuchida K; Mizumoto K; Ohhashi S; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2006 Sep; 12(18):5417-22. PubMed ID: 17000675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
    Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
    Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100P is an early developmental marker of pancreatic carcinogenesis.
    Ohuchida K; Mizumoto K; Egami T; Yamaguchi H; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2006 Sep; 12(18):5411-6. PubMed ID: 17000674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D.
    Whiteman HJ; Weeks ME; Dowen SE; Barry S; Timms JF; Lemoine NR; Crnogorac-Jurcevic T
    Cancer Res; 2007 Sep; 67(18):8633-42. PubMed ID: 17875703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent.
    Crnogorac-Jurcevic T; Missiaglia E; Blaveri E; Gangeswaran R; Jones M; Terris B; Costello E; Neoptolemos JP; Lemoine NR
    J Pathol; 2003 Sep; 201(1):63-74. PubMed ID: 12950018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
    Rehman I; Cross SS; Catto JW; Leiblich A; Mukherjee A; Azzouzi AR; Leung HY; Hamdy FC
    Prostate; 2005 Dec; 65(4):322-30. PubMed ID: 16015609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of ONECUT1 expression in human pancreatic cancer cells.
    Jiang X; Zhang W; Kayed H; Zheng P; Giese NA; Friess H; Kleeff J
    Oncol Rep; 2008 Jan; 19(1):157-63. PubMed ID: 18097590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease.
    Wang L; Friess H; Zhu Z; Graber H; Zimmermann A; Korc M; Reubi JC; Büchler MW
    Clin Cancer Res; 2000 Feb; 6(2):566-71. PubMed ID: 10690540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer.
    Ide Y; Miyoshi E; Nakagawa T; Gu J; Tanemura M; Nishida T; Ito T; Yamamoto H; Kozutsumi Y; Taniguchi N
    Biochem Biophys Res Commun; 2006 Mar; 341(2):478-82. PubMed ID: 16434023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
    Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
    Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
    Ohuchida K; Mizumoto K; Lin C; Yamaguchi H; Ohtsuka T; Sato N; Toma H; Nakamura M; Nagai E; Hashizume M; Tanaka M
    Ann Surg Oncol; 2012 Jul; 19(7):2394-402. PubMed ID: 22407312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of S100A2 and S100A6 in thyroid carcinomas.
    Ito Y; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
    Histopathology; 2005 May; 46(5):569-75. PubMed ID: 15842639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
    Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
    Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of annexin I in human pancreatic cancer and the influence of its down-regulation on biology of this cancer].
    Liu Q; Wang CF; Zhou Z; Hu H; Zhao DB; Ni XG; Bai XF; Gao JD; Tian YT; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):738-41. PubMed ID: 18396684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.